Search Results

You are looking at 1 - 10 of 73 items for :

Clear All
Full access

Mark H. Kawachi

prostatectomy, a technique of robotic radical prostatectomy for management of localized carcinoma of the prostate: experience of over 1100 cases . Urol Clin North Am 2004 ; 31 : 701 – 717 . 2. Webster T Herrell SD Chang SS . Robotic

Full access

Shantanu Tyagi, Arandam Roy, Ravimohan Mavuduru, Girdhar Bora, Tushar Aditya Narain and Arup Kumar Mandal

Background: Historically, the incidence of prostate cancer in India and in nonresident Indians is lower than that in Western populations. Our study aims to assess complications and short-term outcomes of robotic assisted radical prostatectomy (RARP

Full access

Adrian Legaspi, Vanitha Vasudevan, Amit Sastry, Jeronimo Garcialopez de Llano and Marice Ruiz-Conejo

Background: Minimally invasive surgical techniques improve metrics designed to measure quality and efficiency. Compared to open surgery (OS) and laparoscopy (LAP), robotic assisted colorectal surgery (RACS) has shorter length of stay (LOS), less

Full access

William J. Ellis and Paul H. Lange

retropubic prostatectomy: technique and results . J Urol 1998 ; 160 : 2440 – 2445 . 2. Nelson B Kaufman M Broughton G . Comparison of length of stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy . J

Full access

Amanda N. Fader

, laparoscopy is a nice alternative,” she indicated. Robotic-Assisted Laparoscopy Dr. Fader acknowledged that laparoscopy is associated with some problems: the screens are 2-dimensional, the scope is unstable, the instrumentation is long and rigid, the

Full access

Michelle C. Nguyen, Manisha H. Shah, David A. Liebner, Floor J. Backes, John Phay and Lawrence A. Shirley

right adrenal mass. The patient underwent right robotic adrenalectomy in 2016, and pathology results confirmed metastatic melanoma. Pembrolizumab was continued during this time. One year later, the patient developed progression of brain metastases and

Full access

Michael Karass, Rohan Bareja, Ethan Shelkey, Panagiotis J. Vlachostergios, Brian D. Robinson, Francesca Khani, Juan Miguel Mosquera, Douglas S. Scherr, Andrea Sboner, Scott T. Tagawa, Ana M. Molina, Olivier Elemento, David M. Nanus and Bishoy M. Faltas

, gemcitabine/cisplatin; LNs, lymph nodes; NMIBC, non–muscle-invasive bladder cancer; RARC, robot-assisted radical cystectomy; UC, urothelial cancer. The patient was referred for systemic therapy and was enrolled in the CALGB 90601 randomized phase III trial

Full access

Christopher E. Desch

How would you respond to a phone call I got yesterday: “Chris, one of my old college professors called me last night. He is a healthy 67-year-old man with newly diagnosed prostate cancer who is not interested in watchful waiting. Which doctors in Richmond would you recommend?” My friend, a family practice doctor and accomplished healthcare consultant, wanted me to help provide a referral based on my knowledge of cancer care in that community. Although I did give him some names and phone numbers, my role as the local family and neighbor cancer referral service always gives me pause. A couple of thoughts always run through my mind: 1. Do I have enough information to be helpful? Since the first referral for prostate cancer often determines the treatment, my response for this patient might significantly affect patient-centered outcomes. In this case, the referral question was posed by a doctor who knew what information to include (low PSA, T1, Gleasons 5—the real details). However, when my brother calls me about his secretary's sister, it is much less clear. 2. I think I know how good the doctors are in my community but do I really know? I know which doctors have high complication rates, but I have no metrics to evaluate the technical aspects of care. For instance, if the consultant recommends robotic surgery, how much experience does the doctor have with this new technology? What are my favorite doctors' continence, potency, and local failure rates? Frankly, I don't have a clue. I...
Full access

James L. Mohler

based on prostate specific antigen, histological and/or clinical progression . J Urol 2002 ; 167 : 1664 . 7. Menon M Hemal AK . Vattikuti Institute prostatectomy: a technique of robotic radical prostatectomy: experience in more than 1000

Full access

Kathryn P. Pennington, Renata R. Urban and Heidi J. Gray

squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix who were randomized to undergo either open radical hysterectomy (laparotomy) or laparoscopic/robotic radical hysterectomy (type II or III Piver-Rutledge classification